Online citations, reference lists, and bibliographies.
← Back to Search

Mesothelioma Not Associated With Asbestos Exposure.

B. Jasani, A. Gibbs
Published 2012 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
CONTEXT Despite asbestos being identified as the single most important cause of malignant mesothelioma, the tumor is known to occur in only 10% to 20% of heavily exposed individuals. In addition, about 20% of the patients have no history of asbestos exposure even after detailed assessment. Therefore, there has been speculation for some time that asbestos alone may not be sufficient to cause mesothelioma and that other factors may be involved either as cocarcinogens or as independent mechanisms of cancer causation. OBJECTIVE To give a brief review of nonasbestos fiber erionite and therapeutic radiation as 2 established examples of asbestos-independent mechanisms, of the potential emerging role of man-made fibers such as carbon nanotubes, and of polyoma virus SV40 (simian virus 40) as a potential example of the cocarcinogenic mode of involvement. DATA SOURCES Relevant recent literature has been surveyed to portray and provide the evidence in favor of the examples. CONCLUSIONS Erionite has emerged as the most important example of nonasbestos-mediated cause of mesothelioma in regions such as Turkey where exposure to this type of fiber is highly prevalent. Recently, the polyoma virus SV40 has been unexpectedly discovered as an effective cocarcinogen of asbestos in the causation of animal mesothelioma, though despite considerable research, its potential role in human mesothelioma remains unproven.
This paper references
10.1007/s00018-007-6414-6
SV40 association with human malignancies and mechanisms of tumor immunity by large tumor antigen
D. B. Lowe (2007)
10.1093/AJCP/86.2.227
Pleural malignant mesothelioma following Wilms' tumor.
M. Austin (1986)
A multicenter evaluation of assays for detection of SV40 DNA and results in masked mesothelioma specimens.
H. D. Strickler (2001)
10.1093/JNCI/63.1.17
Malignant mesotheliomas in a small village in the Anatolian region of Turkey: an epidemiologic study.
M. Artvinli (1979)
Increased oncogenicity of subclones of SV40 large T-induced neuroectodermal tumor cell lines after loss of large T expression and concomitant mutation in p53.
H. Salewski (1999)
10.4161/cbt.1.4.10
Absence of SV40 in Austrian Tumors Correlates with Low Incidence of Mesotheliomas
A. Leithner (2002)
10.1177/096032719201100615
Intrapleural Administration of Fibres Induces Mesothelioma in Rats in the same Relative Order of Hazard as Occurs in Man after Exposure
P. Carthew (1992)
10.1038/nnano.2008.111
Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study.
Craig A. Poland (2008)
10.1038/sj.bjc.6605848
SV40 associated miRNAs are not detectable in mesotheliomas
G. V. Gee (2010)
10.1002/1097-0142(19880515)61:10<2019::AID-CNCR2820611015>3.0.CO;2-K
Malignant peritoneal mesothelioma after remote abdominal radiation
B. Gilks (1988)
10.1016/S0140-6736(00)04013-7
Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey
Iman Roushdy-Hammady (2001)
10.1164/ARRD.1982.126.3.569
The association of pleural mesothelioma and tuberculosis.
G. Roviaro (1982)
10.1038/nrc947
SV40 and human tumours: myth, association or causality?
A. Gazdar (2002)
SV40 induces mesotheliomas in hamsters.
C. Cicala (1993)
10.1667/RR3095
Site-Specific Cancer Incidence and Mortality after Cerebral Angiography with Radioactive Thorotrast
L. Travis (2003)
10.1073/pnas.0604544103
Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters
B. Kroczynska (2006)
10.1002/IJC.2910630304
Lung carcinoma and malignant mesothelioma in patients exposed to thorotrast: Incidence, histology and p53 status
M. Andersson (1995)
10.1158/0008-5472.CAN-05-4668
A novel SV40 TAg transgenic model of asbestos-induced mesothelioma: malignant transformation is dose dependent.
C. Robinson (2006)
10.2741/JASANI
Simian virus 40 detection in human mesothelioma: reliability and significance of the available molecular evidence.
B. Jasani (2001)
10.1093/JNCI/DJJ106
Prospective study of mesothelioma mortality in Turkish villages with exposure to fibrous zeolite.
Y. Bariş (2006)
10.1016/J.LUNGCAN.2007.03.016
Malignant mesothelioma following thoracic radiotherapy for lung cancer.
S. Witherby (2007)
10.1007/s10653-008-9165-x
Erionite series minerals: mineralogical and carcinogenic properties
A. U. Dogan (2008)
10.1097/00063198-199909000-00011
Pulmonary associations in familial Mediterranean fever.
A. Livneh (1999)
10.1111/j.1749-6632.1967.tb50281.x
EFFECTS OF LOCALLY DEPOSITED COLLOIDAL THORIUM DIOXIDE
S. Dahlgren (1967)
Immunization Safety Review: SV40 Contamination of Polio Vaccine and Cancer
K. Stratton (2002)
10.1002/1097-0142(197510)36:4<1381::AID-CNCR2820360429>3.0.CO;2-X
Malignant peritoneal mesothelioma after cholangiography with thorotrast
R. Maurer (1975)
Experimental studies in metal cancerigenesis. I. Nickel cancers in rats.
W. Hueper (1952)
10.1128/MCB.22.7.2111-2123.2002
Enumeration of the Simian Virus 40 Early Region Elements Necessary for Human Cell Transformation
W. Hahn (2002)
10.1128/JVI.77.9.5039-5045.2003
Simian Virus 40 Infection of Humans
R. Garcea (2003)
10.1053/SONC.2002.30227
The pathogenesis of mesothelioma.
M. Carbone (2002)
10.1186/1743-8977-7-5
Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma
K. Donaldson (2009)
10.1038/196180A0
Experimental Production of Mesothelial Tumours of the Pleura by Implantation of Dusts in Laboratory Animals
J. Wagner (1962)
10.1093/JNCI/DJI278
Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
L. Travis (2005)
10.1093/ANNHYG/30.3.365
Fine biogenic silica fibres in sugar cane: a possible hazard.
R. Newman (1986)
10.1002/(SICI)1097-0142(19960401)77:7<1379::AID-CNCR24>3.0.CO;2-Y
Post‐irradiation malignant mesothelioma
A. Cavazza (1996)
10.1016/S0140-6736(04)17102-X
Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids
F. Lopez-Rios (2004)
10.1038/sj.bjc.6604879
Occupational, domestic and environmental mesothelioma risks in the British population: a case–control study
C. Rake (2009)
10.1186/1743-8977-6-16
Mesothelioma: Do asbestos and carbon nanotubes pose the same health risk?
Marie-Claude F Jaurand (2009)
10.1002/1097-0142(19810701)48:1<134::AID-CNCR2820480124>3.0.CO;2-4
Peritoneal malignant mesothelioma in a patient with recurrent peritonitis
R. Riddell (1981)
10.1007/s10549-007-9509-8
Risk of second non-hematological malignancies among 376,825 breast cancer survivors
L. Brown (2007)
10.1006/SCBI.2000.0346
Association of SV40 with human tumours.
B. Jasani (2001)
10.1002/IJC.2910390104
Epidemiological and environmental evidence of the health effects of exposure to erionite fibres: A four‐year study in the cappadocian region of turkey
I. Bariş (1987)
10.1016/J.SCITOTENV.2003.11.018
Pulmonary fibre burden in sheep living in the Biancavilla area (Sicily): preliminary results.
P. DeNardo (2004)
10.1182/blood-2008-10-184705
Malignant mesothelioma after radiation treatment for Hodgkin lymphoma.
M. D. De Bruin (2009)
10.1158/0008-5472.CAN-05-4642
Genetic predisposition to fiber carcinogenesis causes a mesothelioma epidemic in Turkey.
A. Dogan (2006)
10.2131/JTS.34.65
Induction of mesothelioma by a single intrascrotal administration of multi-wall carbon nanotube in intact male Fischer 344 rats.
Y. Sakamoto (2009)
Mesotheliomas of peritoneum, epicardium, and pericardium induced by strain MC29 avian leukosis virus.
J. F. Chabot (1970)
10.1038/sj.onc.1206552
New developments about the association of SV40 with human mesothelioma
M. Carbone (2003)
North american erionite-associated mesothelioma with pleural plaques and pulmonary fibrosis: a case report.
C. Kliment (2009)
10.1378/CHEST.60.6.564
Diffuse malignant mesothelioma of the pleura: a review of 37 cases.
H. Oels (1971)
10.1002/1097-0142(19850715)56:2<273::AID-CNCR2820560212>3.0.CO;2-0
Malignant pleural mesothelioma following radiotherapy in a 16‐year‐old boy
K. A. Anderson (1985)
10.1097/00000421-199508000-00009
Malignant Peritoneal Mesothelioma After Thorotrast Exposure
C. Stey (1995)
10.1093/AJE/KWH025
Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003.
B. Price (2004)
10.1136/thx.33.2.181
An outbreak of pleural mesothelioma and chronic fibrosing pleurisy in the village of Karain/Urgüp in Anatolia.
Y. Bariş (1978)
10.1002/1097-0142(19850501)55:9<1968::AID-CNCR2820550923>3.0.CO;2-9
Malignant mesothelioma secondary to chronic inflammation and old scars. Two new cases and review of the literature
G. Hillerdal (1985)
Zeolite bodies in human lungs from Turkey.
P. Sebastien (1981)
10.1002/1097-0142(19840901)54:5<951::AID-CNCR2820540536>3.0.CO;2-A
Non‐asbestos‐related malignant mesothelioma. A review
J. T. Peterson (1984)
10.1093/JNCI/23.6.1441
Oncogenic effect of tissue-culture preparations of polyoma virus on fetal mice.
M. Stanton (1959)
10.1093/JNCI/25.5.937
Lung tumors produced by intratracheal inoculation of polyoma virus in Syrian hamsters.
A. Rabson (1960)
10.1007/0-387-28274-2_3
SV40-Mediated Oncogenesis
M. Bocchetta (2005)
10.1002/cncr.22526
Therapeutic radiation for lymphoma
M. J. Teta (2007)
10.1080/19338240903390305
Endemic Malignant Mesothelioma: Exposure to Erionite Is More Important Than Genetic Factors
M. Metintas (2010)
10.1093/JNCI/DJH266
Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States.
E. Engels (2004)
10.1007/s10552-009-9357-4
Ionizing radiation: a risk factor for mesothelioma
J. Goodman (2009)
10.1002/(SICI)1097-0142(19970901)80:5<948::AID-CNCR17>3.0.CO;2-W
Incidence of malignant pleural mesothelioma after thoracic radiotherapy
A. Neugut (1997)
10.1158/0008-5472.CAN-04-2461
Evidence against a role for SV40 in human mesothelioma.
J. Manfredi (2005)
Mesothelioma: is there a background
J. Mcdonald (1994)
10.2307/3580117
The german thorotrast study: recent results and assessment of risks.
G. van Kaick (1999)
10.2131/JTS.33.105
Induction of mesothelioma in p53+/- mouse by intraperitoneal application of multi-wall carbon nanotube.
A. Takagi (2008)
10.1080/00039896.1984.10545828
Ferruginous bodies in sputum as an indication of exposure to airborne mineral fibers in the mesothelioma villages of Cappadocia.
P. Sebastien (1984)
10.1136/oem.58.4.261
Erionite bodies and fibres in bronchoalveolar lavage fluid (BALF) of residents from Tuzköy, Cappadocia, Turkey
P. Dumortier (2001)
10.1097/00001648-199407000-00015
A case-control study of mesothelioma and employment in the Hawaii sugarcane industry.
T. Sinks (1994)
10.1002/1097-0142(19950801)76:3<437::AID-CNCR2820760314>3.0.CO;2-A
Malignant pleural mesothelioma after radiation therapy for breast cancer. A report of two additional patients
V. Shannon (1995)
10.1007/BF01197771
Lack of apparent excess of malignant mesothelioma but increased overall malignancies of peritoneal cavity in Japanese autopsies with Thorotrast injection into blood vessels
Y. Ishikawa (2005)
10.1073/PNAS.170207097
Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity.
M. Bocchetta (2000)
10.1097/01.coc.0000256102.40842.78
An Association Between Postoperative Radiotherapy for Primary Breast Cancer in 11 National Surgical Adjuvant Breast and Bowel Project (NSABP) Studies and the Subsequent Appearance of Pleural Mesothelioma
M. Deutsch (2007)
10.1080/00039890009604036
Unusually High Incidence of Malignant Pleural Mesothelioma in a Town of Eastern Sicily: An Epidemiological and Environmental Study
L. Paoletti (2000)
10.1186/1476-069X-5-20
Fluoro-edenitic fibres in the sputum of subjects from Biancavilla (Sicily): a pilot study
M. G. Putzu (2006)
10.1136/oem.51.12.804
Malignant mesothelioma: attributable risk of asbestos exposure.
R. Spirtas (1994)
10.1002/PATH.1700930204
A primary mesothelioma involving the rectovaginal septum and associated with beryllium.
C. Gold (1967)
10.1007/0-387-28274-2_15
Malignant Mesothelioma and Erionite
A. Dogan (2005)
10.1016/S0140-6736(01)06816-7
Familial malignant mesothelioma
R. Saracci (2001)
10.1144/gsjgs.137.5.0525
Fibrous minerals and health
P. Elmes (1980)
Sedimentary zeolites in the Sierra Madre del Sur and Sierra Madre Occidental, Mexico
M. D. L. C. Garcia (1996)
10.1038/bjc.1985.108
Erionite exposure and mesotheliomas in rats.
J. Wagner (1985)
10.1200/JCO.1983.1.11.695
Malignant mesothelioma following radiation exposure.
K. H. Antman (1983)
10.1667/0033-7587(2001)156[0136:MACAWO]2.0.CO;2
Mortality after Cerebral Angiography with or without Radioactive Thorotrast: An International Cohort of 3,143 Two-Year Survivors
L. Travis (2001)
10.3200/AEOH.58.4.229-232
Pleural Mesothelioma Cases in Biancavilla are Related to a New Fluoro-Edenite Fibrous Amphibole
P. Comba (2003)
10.1200/JCO.2006.09.0936
Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma.
D. Hodgson (2007)
10.1016/S0140-6736(81)91742-6
MALIGNANT MESOTHELIOMA AND RADIOLOGICAL CHEST ABNORMALITIES IN TWO VILLAGES IN CENTRAL TURKEY: An Epidemiological and Environmental Investigation
Y. Bariş (1981)
10.1016/j.ejcts.2007.12.024
Pericardial malignant mesothelioma: a latent complication of radiotherapy?
G. R. Small (2008)
Simian virus 40-like DNA sequences in human pleural mesothelioma.
M. Carbone (1994)
10.1016/0013-9351(84)90136-1
Malignant mesothelioma induced by asbestos and zeolite in the mouse peritoneal cavity.
Y. Suzuki (1984)
10.1200/JCO.2005.03.7101
Is there a role for SV40 in human cancer?
Danielle L Poulin (2006)
10.1002/cncr.21971
The risk of secondary malignancies over 30 years after the treatment of non‐Hodgkin lymphoma
J. Tward (2006)



This paper is referenced by
10.1201/B18107-35
SOME FURTHER INDUSTRIAL, ENVIRONMENTAL AND BIOMEDICAL APPLICATIONS OF HALLOYSITE NANOTUBES
P. Pasbakhsh (2015)
10.1016/j.leukres.2013.03.008
Can SV40 infect and immortalize human B-lymphocytes and mesothelial cells as a natural pathogen?
B. Jasani (2013)
10.13189/EER.2013.010209
Russian Opinion on Asbestos: All Fibers Equal
S. Jargin (2013)
10.2169/internalmedicine.5134-20
The Association between Malignant Pleural Mesothelioma and Thoracic Radiation Therapy for Hodgkin's Lymphoma: The First Case Report in Japan.
K. Nakashima (2020)
10.1155/2012/189170
Malignant Mesothelioma of the Tunica Vaginalis: Presenting with Intermittent Scrotal Pain and Hydrocele
T. Esen (2012)
10.1038/onc.2013.351
Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma
A. Tallet (2014)
10.1177/0748233720918679
Tremolite–actinolite fiber coatings of sub-nanometer silica-rich particles in lungs from deceased Quebec miners
Mark Germine (2020)
10.1097/PAI.0000000000000779
Does Simian Virus 40 (SV40) Have a Role in UK Malignant Pleural Mesothelioma? No Role is Identified in a Sensitive RNA In Situ Hybridization Study on Potentially Affected Birth Cohorts
Fouad S Alchami (2019)
Wczesne i odległe wyniki leczenia złośliwego międzybłoniaka opłucnej na podstawie analizy 170 przypadków
Bryl Maciej (2012)
Environmental Litigation and Toxic Torts Committee Newsletter
Peter Condron (2016)
10.1080/10937404.2016.1193361
Five years update on relationships between malignant pleural mesothelioma and exposure to asbestos and other elongated mineral particles
P. Andujar (2016)
10.13188/2471-4879.1000003
Asbestos-Related Research : First Objectivity then Conclusions
S. Jargin (2016)
10.1016/J.ARBRES.2017.01.007
Mesotelioma pleural maligno en adulto joven sin exposición conocida al asbesto. ¿Se puede descartar realmente la exposición a asbesto?
J. Ferrer (2017)
10.2169/INTERNALMEDICINE.53.0900
Non-asbestos-related malignant pleural mesothelioma.
A. Kanbay (2014)
10.1016/j.yrtph.2013.10.008
Electricians' chrysotile asbestos exposure from electrical products and risks of mesothelioma and lung cancer.
J. Goodman (2014)
10.3892/mco.2020.2131
Malignant mesothelioma metastatic to the oral region and latest topics (Review).
Y. Ohnishi (2020)
THE DEFENSE OF PERICARDIAL MESOTHELIOMA CASES FROM A TO Z
Bruce T. Bishop (2017)
Investigating heterogeneity of growth and drug response in mesotheliomas
Roxanne Otadoy (2013)
Asbestos , Mesothelioma and Lung Cancer : A Comment
S. Jargin (2017)
10.23907/2013.050
Medicolegal Aspects of Asbestos I — Malignant Mesothelioma and Lung Cancer
M. Graham (2013)
10.1007/s10552-013-0230-0
Risk of mesothelioma following external beam radiotherapy for prostate cancer: a cohort analysis of SEER database
A. Farioli (2013)
Malignant pleural mesothelioma : novel biomarkers and related pathways
Filip Mundt (2013)
10.1136/bcr-2013-009850
Unusual presentation and location pleural malignant mesothelioma
A. Kumar (2013)
10.3389/fgene.2014.00151
Tumors that mimic asbestos-related mesothelioma: time to consider a genetics-based tumor registry?
B. Kerger (2014)
10.1016/B978-0-12-386456-7.05311-9
Thoracic Neoplasia–Mesothelioma
D. Jean (2014)
10.1007/s13277-013-1210-4
The function, mechanisms, and role of the genes PTEN and TP53 and the effects of asbestos in the development of malignant mesothelioma: a review focused on the genes' molecular mechanisms
L. D. Assis (2013)
10.5455/JEOS.20141223050627
Asbestos and its substitutes: International coordination and independent research needed -
S. Jargin (2015)
10.20944/preprints201911.0117.v1
Identification of Malignant Mesothelioma Risk Factors through Association Rule Mining
Talha Mahboob Alam (2019)
10.1002/rcm.8906
Laser ablation inductively coupled plasma mass spectrometry as a Novel Clinical Imaging Tool to Detect Asbestos Fibres in Malignant Mesothelioma.
Oana M. Voloaca (2020)
10.1002/jcp.25723
SV40 Infection of Mesenchymal Stromal Cells From Wharton's Jelly Drives the Production of Inflammatory and Tumoral Mediators
C. Cason (2017)
10.1016/j.arbres.2017.01.007
Malignant pleural mesothelioma in a young adult with no known exposure to asbestos. Can asbestos exposure be truly ruled out?
J. Ferrer (2017)
10.11622/SMEDJ.2015053
Malignant mesothelioma of tunica vaginalis: an extremely rare case presenting without risk factors.
Y. Akın (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar